Short interest in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) increased during the last reporting period, rising from 6.67M to 6.80M. This put 18.86% of the company's publicly available shares short.

Short interest for Supernus Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Supernus Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 434.00K shares traded per day, it would take 15.66 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.